Nsclc and egfr activating mutations (EGFRm+).  Experience from a reference center in Greece.

S. Chrysikos (ATHENS, Greece)

Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Chrysikos (ATHENS, Greece). Nsclc and egfr activating mutations (EGFRm+).  Experience from a reference center in Greece.. 4259

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment – prospective data from the Czech TULUNG registry
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020


Genetic and epigenetic analysis of the 17q12-21 locus in the Saguenay–Lac-Saint-Jean (SLSJ) asthma familial cohort.
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018


Comparison of NSCLC patient groups with activated EGFR mutations treated with three different tyrosine-kinase inhibitors (TKI): Real-life data from the Czech Republic
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Target other gene point mutations: HER2 and rare EGFR mutations
Source: ERS Research Seminar
Year: 2015

Tuberculosis incidence in Sardinia (Italy) in the adult population, in the last 8 years (2002-2009): Increase, decrease or stabilization? Preliminary data
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy)
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Mannose-binding lectin promoter polymorphisms and gene variants in pulmonary tuberculosis patients from Cantabria (Northern Spain)
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013

The downstream effects of the 17q12-21 asthma region. Is functional splicing of GSDMB the explanation?
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020


Local clustering of lung carcinoid tumors (LCTs) in a small area of central Greece: genetic abnormalities involving multiple endocrine neoplasia 1 (MEN1) gene on chromosome 11q
Source: Eur Respir J 2005; 26: Suppl. 49, 91s
Year: 2005

The correlation between IRF-7 polymorphism (rs3758650) and tuberculosis in Chinese Han people
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015

The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

Genetic analysis of the mouse bradypneic (bd) mutation
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010


Polymorphism in the length of CA repeat in intron 1 of EGFR of NSCLC in Japan
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

Uncommon EGFR mutations of lung adenocarcinoma in one tertiary institution, Korea: clinical characteristics and treatment response to tyrosine kinase inhibitors
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

A review of in-house Video Observed Therapy (VOT) for patients with active tuberculosis(TB), in a  London teaching hospital.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018




Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
Source: International Congress 2018 – New developments in paediatric asthma
Year: 2018



Utilization of FIXED combination (FC) in the treatment of asthma patients in real life condition in the Czech Republic (UFO)
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012